TRPV4 and cyst: Activation of TRPV4 by 4αPDD and GSK1016790 raises the intracellular Ca+2 levels, which leads to the inhibition of cholangiocyte proliferation in vitro and a reduction in cyst growth in vivo, mediated by the Akt and B-RAF/ERK1/2 signaling pathways [97].